Fengge Wang1,2, Shuxiong Chen1,3, Jishui Wang1,2, Yangping Wang1,2, Fang Ruan1,2, Hua Shu1,2, Liangxi Zhu4,5, Dongmei Man6,7. 1. College of Clinical Medicine, Jining Medical University, Jining, Shandong, China. 2. Department of Obstetric, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. 3. Department of Endocrinology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. 4. College of Clinical Medicine, Jining Medical University, Jining, Shandong, China. zhu87654321@126.com. 5. Department of Obstetric, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. zhu87654321@126.com. 6. College of Clinical Medicine, Jining Medical University, Jining, Shandong, China. mandongmei@163.com. 7. Department of Obstetric, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. mandongmei@163.com.
Abstract
PURPOSE: Our objective of this study was to investigate whether first trimester serum pregnancy-associated plasma protein-A (PAPP-A) differed amongst pregnancies with placenta previa-accreta and non-adherent placenta previa and healthy pregnancies by a retrospective cohort analysis. METHODS: A total of 177 pregnant females were included in the study, as follows: 35 cases of placenta previa-accreta, 30 cases of non-adherent placenta previa, and 112 cases of BMI and age matched, healthy pregnant controls. PAPP-A multiples of the median (MoM) were acquired from laboratory data files in 1 January 2017-30 September 2019. The probable maternal serum biochemical predictor of placenta accreta was analyzed by using multiple logistic regression analysis. RESULTS: PAPP-A MoM of placenta previa-accreta group was significantly higher than those of the non-adherent placenta previa group and control group (p = 0.009 < 0.05, p < 0.001). Serum PAPP-A was found to be significantly positively associated with placenta accreta after adjusted gestational week at time of blood sampling, BMI, age, smoking, and previous cesarean section history (OR: 3.51; 95% CI: 1.77-6.94; p = 0.0003 < 0.05). In addition, smoking (OR: 9.17; 95% CI: 1.69-49.62; p = 0.010 < 0.05) and previous cesarean section history (OR: 2.75; 95% CI: 1.23-6.17; p = 0.014 < 0.05) were also significantly associated with placenta accreta. CONCLUSION: Increased first trimester serum PAPP-A was significantly positively associated with placenta accreta, suggesting that the potential role of PAPP-A in identifying pregnancies at high risk for placenta accreta. Smoking and previous cesarean section history may be the risk factors for accreta in placenta previa patients.
PURPOSE: Our objective of this study was to investigate whether first trimester serum pregnancy-associated plasma protein-A (PAPP-A) differed amongst pregnancies with placenta previa-accreta and non-adherent placenta previa and healthy pregnancies by a retrospective cohort analysis. METHODS: A total of 177 pregnant females were included in the study, as follows: 35 cases of placenta previa-accreta, 30 cases of non-adherent placenta previa, and 112 cases of BMI and age matched, healthy pregnant controls. PAPP-A multiples of the median (MoM) were acquired from laboratory data files in 1 January 2017-30 September 2019. The probable maternal serum biochemical predictor of placenta accreta was analyzed by using multiple logistic regression analysis. RESULTS:PAPP-A MoM of placenta previa-accreta group was significantly higher than those of the non-adherent placenta previa group and control group (p = 0.009 < 0.05, p < 0.001). Serum PAPP-A was found to be significantly positively associated with placenta accreta after adjusted gestational week at time of blood sampling, BMI, age, smoking, and previous cesarean section history (OR: 3.51; 95% CI: 1.77-6.94; p = 0.0003 < 0.05). In addition, smoking (OR: 9.17; 95% CI: 1.69-49.62; p = 0.010 < 0.05) and previous cesarean section history (OR: 2.75; 95% CI: 1.23-6.17; p = 0.014 < 0.05) were also significantly associated with placenta accreta. CONCLUSION: Increased first trimester serum PAPP-A was significantly positively associated with placenta accreta, suggesting that the potential role of PAPP-A in identifying pregnancies at high risk for placenta accreta. Smoking and previous cesarean section history may be the risk factors for accreta in placenta previa patients.
Entities:
Keywords:
Association; First trimester serum; PAPP-A; Placenta accreta
Authors: Lorraine Dugoff; John C Hobbins; Fergal D Malone; T Flint Porter; David Luthy; Christine H Comstock; Gary Hankins; Richard L Berkowitz; Irwin Merkatz; Sabrina D Craigo; Ilan E Timor-Tritsch; Steven R Carr; Honor M Wolfe; John Vidaver; Mary E D'Alton Journal: Am J Obstet Gynecol Date: 2004-10 Impact factor: 8.661
Authors: Christine H Comstock; Joseph J Love; Richard A Bronsteen; Wesley Lee; Ivana M Vettraino; Raywin R Huang; Robert P Lorenz Journal: Am J Obstet Gynecol Date: 2004-04 Impact factor: 8.661
Authors: Shahryar K Kavoussi; Shu-Hung Chen; John David Wininger; Arnav Lal; William E Roudebush; Hayes C Lanford; Amy S Esqueda; Maya Barsky; Dan I Lebovic; Parviz K Kavoussi; Melissa S Gilkey; Justin Chen; Graham L Machen; Renee J Chosed Journal: J Assist Reprod Genet Date: 2022-01-11 Impact factor: 3.412